Leaflet IVACAFTOR TEVA 150mg film-coated tablets

Product code:
W72205001
Indicated for:
cystic fibrosis
Route of administration:
oral
Substance:
ivacaftor (CFTR modulator)
ATC
R07AX02 — Respiratory system | Other respiratory system products | Other respiratory system products
Ivacaftor is a medication used for the treatment of cystic fibrosis in patients with specific CFTR gene mutations. It works by improving the function of the CFTR protein, facilitating chloride transport across cell membranes.

The medication is taken orally, usually twice daily with fat-containing food, as directed by a doctor. It is important to follow the treatment regimen to achieve the best results.

Side effects may include headache, abdominal pain, diarrhea, or skin rashes. In rare cases, severe hepatic reactions or elevated liver enzymes may occur.

Ivacaftor is not recommended for patients with hypersensitivity to this medication or severe hepatic impairment.

General data about IVACAFTOR TEVA 150mg

Substance:
ivacaftor
Product code:
W72205001
Concentration:
150mg
Pharmaceutical form:
film-coated tablets
Product type:
Generic medicine
Prescription status:
S — Medicines dispensed with a restricted medical prescription, reserved for use in certain specialized fields.

Marketing authorisation

Manufacturer:
ACTAVIS INTERNATIONAL LTD - MALTA
Holder:
TEVA B.V. - TARILE DE JOS
Number:
16856/2026/01
Shelf life:
2 years

Pharmaceutical forms available for ivacaftor

Concentrations available for ivacaftor

  • 150mg
  • 25mg
  • 50mg
  • 59.5mg
  • 75mg